Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 8

Evaluation of the Systemic Immune-Inflammation Index and Hemoglobin Albumin Lymphocyte Platelet Score in Celiac Patients: A Retrospective Single-Center Study

Aycan Acet(KUTAHYA HEALTH SCIENCES UNIVERSITY)0000-0002-9395-3366
Süleyman Coşgun(Kütahya Sağlık Bilimleri Üniversitesi)0000-0001-9417-3671
Cengiz Koçak(Kütahya Sağlık Bilimleri Üniversitesi)0000-0003-3819-6822
Türkan Paşalı Kilit(Kütahya Sağlık Bilimleri Üniversitesi)0000-0003-1126-7336
Sertaş Erarslan(Kütahya Sağlık Bilimleri Üniversitesi)0000-0002-6816-4154
Çağla Özdemir(Kütahya Sağlık Bilimleri Üniversitesi)0000-0002-9766-1918
Ayşenur Karayel(Kütahya Sağlık Bilimleri Üniversitesi)0009-0007-9293-0633
Cumali Yalçın(Kütahya Sağlık Bilimleri Üniversitesi)0000-0002-5129-2977
Pages
—
Publication Date
2026-08-09
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this single-center retrospective cohort, SII and HALP scores showed limited diagnostic and prognostic utility in newly diagnosed CD and, on the basis of the present data, did not reliably forecast histopathological severity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Celiac disease (CD) is a chronic immune-mediated enteropathy diagnosed using serological tests and histopathological evaluation of duodenal biopsies according to the Marsh classification.
📊
Key Findings & Data:Methods: This retrospective observational study included 112 participants: 51 patients with newly diagnosed CD and 61 age- and sex-matched controls.
💡
Conclusion & Impact:Conclusion: In this single-center retrospective cohort, SII and HALP scores showed limited diagnostic and prognostic utility in newly diagnosed CD and, on the basis of the present data, did not reliably forecast histopathological severity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Celiac disease · Systemic immune-inflammation index · HALP score

Abstract

Objective: Celiac disease (CD) is a chronic immune-mediated enteropathy diagnosed using serological tests and histopathological evaluation of duodenal biopsies according to the Marsh classification. Because biopsy is invasive, attention has shifted toward simple inflammatory biomarkers derived from routine laboratory parameters, such as the Systemic Immune-Inflammation Index (SII) and hemoglobin–albumin–lymphocyte–platelet (HALP) score, which reflect systemic inflammatory and immune-nutritional status. This study evaluated the diagnostic value of SII and HALP and their ability to predict the histopathological severity in patients with CD. Methods: This retrospective observational study included 112 participants: 51 patients with newly diagnosed CD and 61 age- and sex-matched controls. CD was confirmed according to the European Society for the Study of Coeliac Disease criteria, and patients were classified as having Marsh 2 or Marsh 3 disease. SII and HALP indices were derived from routine laboratory parameters. Comparative analyses, ROC curve assessments, and multivariate logistic regression were conducted, with significance set at p < 0.05. Results: Patients with CD showed significantly lower hemoglobin, ferritin, and total iron-binding capacity than controls (p < 0.05), whereas SII and HALP did not differ significantly between groups. Tissue transglutaminase IgA and anti-endomysial IgA positivity were markedly higher in Marsh 3 than in Marsh 2 patients. ROC analysis showed limited diagnostic utility for HALP (AUC = 0.589) and no significant performance for SII (AUC = 0.479). Neither index predicted advanced villous atrophy (HALP AUC = 0.623; SII AUC = 0.611) nor emerged as an independent predictor in the regression analysis. Conclusion: In this single-center retrospective cohort, SII and HALP scores showed limited diagnostic and prognostic utility in newly diagnosed CD and, on the basis of the present data, did not reliably forecast histopathological severity.

🔖

Cite This Article

Acet, A., Coşgun, S., Koçak, C., Kilit, T. P., Erarslan, S., Özdemir, Ç., Karayel, A., Yalçın, C. (2026). Evaluation of the Systemic Immune-Inflammation Index and Hemoglobin Albumin Lymphocyte Platelet Score in Celiac Patients: A Retrospective Single-Center Study. Turkish Journal of Internal Medicine, Volume: 8. https://doi.org/10.46310/tjim.1976086

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330-54. doi:10.1016/0016-5085(92)91819-P.
  2. Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019;7(5):583-613. doi:10.1177/2050640619844125.
  3. Taştemur Ş, Felek D. Evaluation of systemic inflammation associated with celiac disease. Turkish Journal of Clinics and Laboratory. 2026;16(4):449-55. doi:10.18663/tjcl.1701414.
  4. Cakir I, Dogan S. Association between systemic immune inflammation index and newly diagnosed adult celiac disease. Turk J Biochem. 2022;47(1):59-64. doi:10.1515/tjb-2021-0053.
  5. Kivrakoglu F, Ergin M, Kosar K. Evaluation of the systemic immune-inflammation index in relation to histological stages of celiac disease. Eur J Med Res. 2025;30:694. doi:10.1186/s40001-025-02973-x.
  6. Çiftel E, Atlı H, Dayanan R, Genç S, Mercantepe F. Assessing the role of inflammatory and nutritional biomarkers in the diagnosis of celiac disease. Anatolian Current Medical Journal. 2025;7(4):506-12. doi:10.38053/acmj.1732459.
  7. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185-94. doi:10.1097/00042737-199910000-00019.
  8. Iversen R, Sollid LM. The immunobiology and pathogenesis of celiac disease. Annu Rev Pathol. 2023;18:47-70. doi:10.1146/annurev-pathmechdis-031521-032634.
  9. Abangah G, Asadollahi R, Rahmani A, Asadollahi K, Teimouri H. Plasma inflammatory cytokines as predictor markers for severity of histological variations of intestine among celiac patients. International Journal of Celiac Disease. 2014;2(2):54-7. doi:10.12691/ijcd-2-2-6.
  10. Asfuroğlu Kalkan E. Platelet indices in determination of Marsh classification in new diagnosed celiac patients. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2022;75(2):199-203.
  11. Palmacci F, Toti E, Raguzzini A, Catasta G, Aiello P, Peluso I, et al. Neutrophil-to-lymphocyte ratio, Mediterranean diet, and bone health in coeliac disease patients: a pilot study. Oxid Med Cell Longev. 2019;2019(1):7384193. doi:10.1155/2019/7384193.
  12. Chandrakar A. Exploring diverse aspects of celiac disease: a review. Recent Research in Science and Technology. 2024;16:15-25. doi:10.25081/rrst.2024.16.8885.
  13. Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114:109496. doi:10.1016/j.intimp.2022.109496.
  14. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693-700. doi:10.2337/diabetes.53.3.693.
  15. Cui B, Sun Y, Cao D, Zhang J, Sui X, Liu Y, et al. Association between the systemic immune-inflammation index and mortality risk in myocardial infarction patients: a retrospective cohort study. Eur J Med Res. 2025;30(1):1156. doi:10.1186/s40001-025-03399-1.
  16. Zhang C, Li M, Liu L, Deng L, Yulei X, Zhong Y, et al. Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention: a meta-analysis of cohort studies. BMC Cardiovasc Disord. 2024;24(1):189. doi:10.1186/s12872-024-03849-4.
  17. Yu J, Zuo T, Peng S, Xu D. Diagnostic and prognostic value of systemic immune-inflammation index for heart failure: a systematic review and meta-analysis. Front Cardiovasc Med. 2025;12:1499449. doi:10.3389/fcvm.2025.1499449.
  18. Farag CM, Antar R, Akosman S, Ng M, Whalen MJ. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget. 2023;14:153-72. doi:10.18632/oncotarget.28367.
  19. Qian C, Liu J, Meng C, Cheng J, Wu B, Liao J. The significant prognostic value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score in digestive system cancers: a systematic review and meta-analysis. BMC Cancer. 2025;25:1577. doi:10.1186/s12885-025-15068-x.
  20. Zhang M, Xie C, Liu S, Fan H, Li Z, Tong X. The prognostic value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score in lung cancer: a systematic review and meta-analysis. J Clin Med. 2025;14(16):5701. doi:10.3390/jcm14165701.